Your session is about to expire
← Back to Search
Behavioral Intervention
Family Nurture Intervention (FNI) for Mother-infant Bonding during COVID-19
N/A
Recruiting
Led By Dani Dumitriu, MD, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4 months, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trialwill compare mother-infant emotional connection in standard care vs. Family Nurture Intervention, to examine how these interactions affect neurodevelopment. Assessments will include videos & surveys to track progress.
Who is the study for?
This trial is for mothers with newborns born between 37 and 40 weeks +6 days, who speak English or Spanish, and agree to participate in linked studies. Excluded are infants needing special care due to anomalies, those advised against by physicians due to health concerns or maternal history of substance abuse/psychosis, multiples like twins, and mothers unwilling to be recorded.
What is being tested?
The study tests if promoting emotional exchange (EE) between mother-infant pairs improves relational health and child development compared to standard newborn care education (NC). It involves observing interactions through videos during sessions and follow-up surveys from a related study.
What are the potential side effects?
There are no direct medical side effects discussed for this intervention as it focuses on educational and behavioral techniques rather than pharmaceutical treatments.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 4 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4 months, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Emotional Synchrony (ES) Scale
Change in Maternal Caregiving Behavior Score
Postpartum Bonding Questionnaire (PBQ)
Secondary study objectives
Change in Ages and Stages questionnaire (ASQ-3) Score
Change in Social-Emotional Questionnaire (ASQ-SE) Score
Maternal Anxiety using the State/Trait Anxiety Index (STAI)
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Emotional Exchange (EE)Experimental Treatment1 Intervention
Receives a facilitated emotional exchange session over Zoom in the Well Baby Nursery and up to 7 subsequent Zoom sessions over the next 4 months.
Group II: Newborn Care (NC)Active Control1 Intervention
Receives didactic newborn parenting education delivering developmentally appropriate content over zoom at the same time points as the emotional exchange group.
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,489 Previous Clinical Trials
2,663,683 Total Patients Enrolled
Dani Dumitriu, MD, PhDPrincipal Investigator - Columbia University
Columbia University
1 Previous Clinical Trials
82 Total Patients Enrolled
Dani DumitriuPrincipal Investigator - Columbia University
Columbia University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your baby has a medical condition that requires specialized care beyond what is typically needed for newborns.The baby is the only one born during delivery.The mother or infant has a medical condition that prevents them from participating in the study.The mother does not want to wear a device that records her and her newborn's heart activity.
Research Study Groups:
This trial has the following groups:- Group 1: Newborn Care (NC)
- Group 2: Emotional Exchange (EE)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger